oral semaglutide trade name Sem-O™ - Getz Pharma US FDA accepts Novo Nordisk's
Description
#PharmaIndustry #GLP1 #PatentCliff #ObesityTreatment #DiabetesCare #IndianPharma #Biologics

Learn about the new Wegovy Pill.

Increased risk of diabetic retinopathy complications in patients with a history of the condition

In conjunction with all the effects, GLP-1 RAs have been found to lower weight and aid in weight management.
And worth being rigorous about

itemCode-1198562
